Filter By Industry
Filter By Tag


RNL BIO CO LTD Press releases

1 - 10 of 26 Press Releases

Feb 08, 2013
RNL BIO sumitted IND for pase II and III clinical trial to Korea FDA to treat cerebral palsy using autologous fat derived stem cells.

Dec 24, 2010
Two autologous stem cell therapy sessions prevented patient from foot amputation

Dec 06, 2009
-Electromyogram (EMG) findings show improvement in conduction speed and latency -RNL Bio’s stem cell therapy demonstrates effective outcomes

Jul 15, 2009
Patient’s own fat-derived stem cell cured severe atopic syndrome

Apr 30, 2009
Korean-FDA approved RNL’s Astrostem based on patient’s own fat derived stem cells to treat spinal cord injury. Phase I human trial will be done by intravenous infusion of stem cells at Sam Hospital in Anyang, South Korea

Feb 27, 2009
RNL Bio successfully cloned a small breed Pekingese commercially for the first time in the world.

Feb 20, 2009
As a promotion from RNL Bio, pet owners who register RNL's stem cell bank for animals will have unique opportunity for free stem cell therapy for their pets.

Feb 13, 2009
RNL Bio successfully treated a horse with syndesmitis and it will return to race track soon.

Jan 29, 2009
RNL Bio made another breakthrough in dog cloning history. Two clones were born from a Beagle donor's stem cells instead of skin cells.

Jan 28, 2009
Intravenous delivery of adipose derived stem cells showed effects on liver function restoration

Page: 1 2 3 Next